Drug General Information
Drug ID
D0M5TM
Former ID
DNC012806
Drug Name
8-(3-Fluoro-phenyl)-9-methyl-9H-purin-6-ylamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [525962]
Structure
Download
2D MOL

3D MOL

Formula
C12H10FN5
Canonical SMILES
CN1C2=C(C(=NC=N2)N)N=C1C3=CC(=CC=C3)F
InChI
1S/C12H10FN5/c1-18-11(7-3-2-4-8(13)5-7)17-9-10(14)15-6-16-12(9)18/h2-6H,1H3,(H2,14,15,16)
InChIKey
JXJYLIUAIVDUNX-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Adenosine A2b receptor Target Info Inhibitor [525962]
KEGG Pathway Rap1 signaling pathway
Calcium signaling pathway
Neuroactive ligand-receptor interaction
Vascular smooth muscle contraction
Alcoholism
NetPath Pathway TGF_beta_Receptor Signaling Pathway
TCR Signaling Pathway
Pathway Interaction Database C-MYB transcription factor network
PathWhiz Pathway Intracellular Signalling Through Adenosine Receptor A2b and Adenosine
Reactome Adenosine P1 receptors
G alpha (s) signalling events
Surfactant metabolism
WikiPathways Nucleotide GPCRs
GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 525962J Med Chem. 2001 Jan 18;44(2):170-9.2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor.
Ref 525962J Med Chem. 2001 Jan 18;44(2):170-9.2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.